title: [Resection surgery in malignant neoplasms of the exocrine pancreas: our experience, 1987-1994].
abstract: From 1987 to 1994, 24 patients underwent resection for pancreatic cancer; they represented 24% of all patients observed in that period. Surgical procedures were a pancreatoduodenectomy (PD) in 20 cases, a distal pancreatectomy in 4 cases, a palliative intervention in 61 cases, an exploratory laparotomy in 13 cases and a video laparoscopy in 2 cases. Adjuvant treatments were given in addition to resection in 20 patients. In the 20 patients undergoing PD, mortality was 20% and morbidity 20%. There was no mortality and no morbidity in distal pancreatectomy. The 1-year survival in pancreatoduodenectomy was 50% and 0% for distal pancreatectomy. Pancreatic resection, radical and palliative, whenever technically possible, represents the treatment of choice for pancreatic cancer.
authors.affiliation: I Divisione di Chirurgia Generale, Azienda Ospedaliera, Ospedale Carlo Poma, Mantova.
authors.forename: S
authors.initials: S
authors.lastname: Ghidoni
authors.forename: T
authors.initials: T
authors.lastname: Bruni
authors.forename: A
authors.initials: A
authors.lastname: Viotto
authors.forename: C
authors.initials: C
authors.lastname: Pulica
authors.forename: O
authors.initials: O
authors.lastname: Bruni
authors.forename: L
authors.initials: L
authors.lastname: Francia
authors.forename: M
authors.initials: M
authors.lastname: Tedoli
authors.forename: G
authors.initials: G
authors.lastname: Caleffi
authors.forename: M
authors.initials: M
authors.lastname: Busani
authors.forename: P
authors.initials: P
authors.lastname: Tenchini
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000601:surgery*; D016577:Pancreaticoduodenectomy; D011788:Quality of Life; D012189:Retrospective Studies
vernacular_title: La chirurgia resettiva nelle neoplasie maligne del pancreas esocrino: nostra esperienza 1987-1994.